1
|
Eads D, Buehler L, Esbenshade A, Fly J, Miller E, Redmond H, Ritter E, Tynes C, Wittmann S, Roghair P, Childers E. One Health in action: flea control and interpretative education at Badlands National Park. J Vector Ecol 2022; 47:227-229. [PMID: 36314678 DOI: 10.52707/1081-1710-47.2.227] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Affiliation(s)
- David Eads
- U.S. Geological Survey, Fort Collins Science Center, CO, U.S.A.,
| | - Lindsey Buehler
- Prairie Wildlife Research, WI, U.S.A
- National Park Service, Badlands National Park, SD, U.S.A
| | | | - Jason Fly
- National Park Service, Badlands National Park, SD, U.S.A
| | - Evan Miller
- National Park Service, Badlands National Park, SD, U.S.A
| | - Holly Redmond
- National Park Service, Badlands National Park, SD, U.S.A
| | - Emily Ritter
- National Park Service, Badlands National Park, SD, U.S.A
| | - Caitlyn Tynes
- National Park Service, Badlands National Park, SD, U.S.A
| | - Sasha Wittmann
- National Park Service, Badlands National Park, SD, U.S.A
| | - Paul Roghair
- National Park Service, Badlands National Park, SD, U.S.A
| | - Eddie Childers
- National Park Service, Badlands National Park, SD, U.S.A
| |
Collapse
|
2
|
Eads D, Livieri T, Tretten T, Hughes J, Kaczor N, Halsell E, Grassel S, Dobesh P, Childers E, Lucas D, Noble L, Vasquez M, Grady AC, Biggins D. Assembling a safe and effective toolbox for integrated flea control and plague mitigation: Fipronil experiments with prairie dogs. PLoS One 2022; 17:e0272419. [PMID: 35939486 PMCID: PMC9359584 DOI: 10.1371/journal.pone.0272419] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2022] [Accepted: 07/19/2022] [Indexed: 11/19/2022] Open
Abstract
Background Plague, a widely distributed zoonotic disease of mammalian hosts and flea vectors, poses a significant risk to ecosystems throughout much of Earth. Conservation biologists use insecticides for flea control and plague mitigation. Here, we evaluate the use of an insecticide grain bait, laced with 0.005% fipronil (FIP) by weight, with black-tailed prairie dogs (BTPDs, Cynomys ludovicianus). We consider safety measures, flea control, BTPD body condition, BTPD survival, efficacy of plague mitigation, and the speed of FIP grain application vs. infusing BTPD burrows with insecticide dusts. We also explore conservation implications for endangered black-footed ferrets (Mustela nigripes), which are specialized predators of Cynomys. Principal findings During 5- and 10-day laboratory trials in Colorado, USA, 2016–2017, FIP grain had no detectable acute toxic effect on 20 BTPDs that readily consumed the grain. During field experiments in South Dakota, USA, 2016–2020, FIP grain suppressed fleas on BTPDs for at least 12 months and up to 24 months in many cases; short-term flea control on a few sites was poor for unknown reasons. In an area of South Dakota where plague circulation appeared low or absent, FIP grain had no detectable effect, positive or negative, on BTPD survival. Experimental results suggest FIP grain may have improved BTPD body condition (mass:foot) and reproduction (juveniles:adults). During a 2019 plague epizootic in Colorado, BTPDs on 238 ha habitat were protected by FIP grain, whereas BTPDs were nearly eliminated on non-treated habitat. Applications of FIP grain were 2–4 times faster than dusting BTPD burrows. Significance Deltamethrin dust is the most commonly used insecticide for plague mitigation on Cynomys colonies. Fleas on BTPD colonies exhibit the ability to evolve resistance to deltamethrin after repeated annual treatments. Thus, more tools are needed. Accumulating data show orally-delivered FIP is safe and usually effective for flea control with BTPDs, though potential acute toxic effects cannot be ruled out. With continued study and refinement, FIP might be used in rotation with, or even replace deltamethrin, and serve an important role in Cynomys and black-footed ferret conservation. More broadly, our stepwise approach to research on FIP may function as a template or guide for evaluations of insecticides in the context of wildlife conservation.
Collapse
Affiliation(s)
- David Eads
- U.S. Geological Survey, Fort Collins Science Center, Fort Collins, Colorado, United States of America
- * E-mail:
| | - Travis Livieri
- Prairie Wildlife Research, Stevens Point, Wisconsin, United States of America
| | - Tyler Tretten
- U.S. Fish and Wildlife Service, National Black-Footed Ferret Conservation Center, Carr, Colorado, United States of America
| | - John Hughes
- U.S. Fish and Wildlife Service, National Black-Footed Ferret Conservation Center, Carr, Colorado, United States of America
| | - Nick Kaczor
- U.S. Fish and Wildlife Service, Colorado Front Range National Wildlife Refuge Complex, Arvada, Colorado, United States of America
| | - Emily Halsell
- U.S. Fish and Wildlife Service, Colorado Front Range National Wildlife Refuge Complex, Arvada, Colorado, United States of America
| | - Shaun Grassel
- Lower Brule Sioux Tribe, Lower Brule, South Dakota, United States of America
| | - Phillip Dobesh
- U.S. Forest Service, Wall Ranger District, Wall, South Dakota, United States of America
| | - Eddie Childers
- National Park Service, Badlands National Park, Rapid City, South Dakota, United States of America
| | - David Lucas
- U.S. Fish and Wildlife Service, Colorado Front Range National Wildlife Refuge Complex, Arvada, Colorado, United States of America
| | - Lauren Noble
- U.S. Geological Survey, Fort Collins Science Center, Fort Collins, Colorado, United States of America
| | - Michele Vasquez
- U.S. Geological Survey, Fort Collins Science Center, Fort Collins, Colorado, United States of America
| | - Anna Catherine Grady
- U.S. Geological Survey, Fort Collins Science Center, Fort Collins, Colorado, United States of America
| | - Dean Biggins
- U.S. Geological Survey, Fort Collins Science Center, Fort Collins, Colorado, United States of America
| |
Collapse
|
3
|
Gentry Z, Boitano T, Smith H, Russell J, Eads D, Straughn J. A cost analysis of the impact of enhanced recovery after surgery (ERAS) protocol in gynecologic oncology surgery. Gynecol Oncol 2019. [DOI: 10.1016/j.ygyno.2019.04.489] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
4
|
Eads D, Hansen R, Oyegunwa A, Cecil C, Culver C, Scholle F, Petty I, Laster S. Terameprocol, a methylated derivative of nordihydroguaiaretic acid, inhibits production of prostaglandins and several key inflammatory cytokines and chemokines. J Inflamm (Lond) 2009; 6:2. [PMID: 19133137 PMCID: PMC2631502 DOI: 10.1186/1476-9255-6-2] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/30/2008] [Accepted: 01/08/2009] [Indexed: 01/05/2023]
Abstract
BACKGROUND Extracts of the creosote bush, Larrea tridentata, have been used for centuries by natives of western American and Mexican deserts to treat a variety of infectious diseases and inflammatory disorders. The beneficial activity of this plant has been linked to the compound nordihydroguaiaretic acid (NDGA) and its various substituted derivatives. Recently, tetra-O-methyl NDGA or terameprocol (TMP) has been shown to inhibit the growth of certain tumor-derived cell lines and is now in clinical trials for the treatment of human cancer. In this report, we ask whether TMP also displays anti-inflammatory activity. TMP was tested for its ability to inhibit the LPS-induced production of inflammatory lipids and cytokines in vitro. We also examined the effects of TMP on production of TNF-alpha in C57BL6/J mice following a sublethal challenge with LPS. Finally, we examined the molecular mechanisms underlying the effects we observed. METHODS RAW 264.7 cells and resident peritoneal macrophages from C57BL6/J mice, stimulated with 1 mug/ml LPS, were used in experiments designed to measure the effects of TMP on the production of prostaglandins, cytokines and chemokines. Prostaglandin production was determined by ELISA. Cytokine and chemokine production were determined by antibody array and ELISA.Western blots, q-RT-PCR, and enzyme assays were used to assess the effects of TMP on expression and activity of COX-2.q-RT-PCR was used to assess the effects of TMP on levels of cytokine and chemokine mRNA.C57BL6/J mice injected i.p. with LPS were used in experiments designed to measure the effects of TMP in vivo. Serum levels of TNF-alpha were determined by ELISA. RESULTS TMP strongly inhibited the production of prostaglandins from RAW 264.7 cells and normal peritoneal macrophages. This effect correlated with a TMP-dependent reduction in levels of COX-2 mRNA and protein, and inhibition of the enzymatic activity of COX-2.TMP inhibited, to varying degrees, the production of several cytokines, and chemokines from RAW 264.7 macrophages and normal peritoneal macrophages. Affected molecules included TNF-alpha and MCP-1. Levels of cytokine mRNA were affected similarly, suggesting that TMP is acting to prevent gene expression.TMP partially blocked the production of TNF-alpha and MCP-1 in vivo in the serum of C57BL6/J mice that were challenged i.p. with LPS. CONCLUSION TMP inhibited the LPS-induced production of lipid mediators and several key inflammatory cytokines and chemokines, both in vitro and in vivo, raising the possibility that TMP might be useful as a treatment for a variety of inflammatory disorders.
Collapse
Affiliation(s)
- D Eads
- Department of Microbiology, North Carolina State University, Raleigh, NC 27695, USA.
| | | | | | | | | | | | | | | |
Collapse
|
5
|
Dunlap N, Schwartz GG, Eads D, Cramer SD, Sherk AB, John V, Koumenis C. 1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising radiation on human prostate cancer cells. Br J Cancer 2003; 89:746-53. [PMID: 12915889 PMCID: PMC2376931 DOI: 10.1038/sj.bjc.6601161] [Citation(s) in RCA: 57] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
Radiotherapy with external beam radiation or brachytherapy is an established therapeutic modality for prostate cancer. Approximately 30% of patients with localised prostate cancer relapse at the irradiated site. Secondary effects of ionising radiation (IR), for example, bowel and bladder complications, are common. Thus, the search for biological response modifiers that could potentiate the therapeutic effects of radiation and limit the occurrence of serious side effects is an important task in prostate cancer therapy. 1alpha,25-Dihydroxyvitamin D(3) (calcitriol), the active metabolite of vitamin D, and its analogues are under investigation for the treatment of several malignancies including prostate cancer. Here, we report that 1alpha,25-dihydroxyvitamin D(3) and its less calcaemic analogue 19-nor-1alpha,25-(OH)(2)D(2) (Zemplar) act synergistically with IR to inhibit the growth of the human prostate cancer cells in vitro. 1alpha,25-dihydroxyvitamin D(3) potentiated IR-induced apoptosis of LNCaP cells, and nanomolar doses of 1alpha,25-dihydroxyvitamin D(3) and 19-nor-1alpha,25-(OH)(2)D(2) showed synergistic inhibition of growth of LNCaP cells at radiobiologically relevant doses of IR (1-2 Gy). At higher doses of IR, the combination of 1alpha,25-dihydroxyvitamin D(3) and IR or 19-nor-1alpha,25-(OH)(2)D(2) and IR resulted in moderate antagonism. The synergistic effect at radiobiologically relevant doses of radiation suggests that a combination of 1alpha,25-dihydroxyvitamin D(3) or 19-nor-1alpha,25-(OH)(2)D(2) with IR could permit a reduction in the dose of radiation given clinically and thus potentially reduce treatment-related morbidity.
Collapse
Affiliation(s)
- N Dunlap
- Department of Radiation Oncology, Comprehensive Cancer Center of Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
| | - G G Schwartz
- Cancer Biology, Comprehensive Cancer Center of Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
- Department of Public Health Sciences, Comprehensive Cancer Center of Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
| | - D Eads
- Department of Radiation Oncology, Comprehensive Cancer Center of Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
| | - S D Cramer
- Cancer Biology, Comprehensive Cancer Center of Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
- Department of Urology, Comprehensive Cancer Center of Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
| | - A B Sherk
- Cancer Biology, Comprehensive Cancer Center of Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
| | - V John
- Department of Radiation Oncology, Comprehensive Cancer Center of Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
| | - C Koumenis
- Department of Radiation Oncology, Comprehensive Cancer Center of Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
- Cancer Biology, Comprehensive Cancer Center of Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
- Department of Radiation Oncology, Comprehensive Cancer Center of Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA. E-mail:
| |
Collapse
|
6
|
Syed AM, Puthawala A, Fleming P, Neblett D, Gowdy RA, Sheikh KM, George FW, Eads D, McNamara C. Combination of external and interstitial irradiation in the primary management of breast carcinoma. Cancer 1980; 46:1360-5. [PMID: 7417936 DOI: 10.1002/1097-0142(19800915)46:6<1360::aid-cncr2820460612>3.0.co;2-k] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
The authors treated 83 patients with carcinoma of the breast using a combination of external and interstitial irradiation at Los Angeles County--University of Southern California Medical Center and Southern California Cancer Center between February 1, 1974, and May 31, 1977. All 30 patients who had T1 and T2 lesions, and who were followed for a minimum period of 24 months (24-50 months) are clinically still free of disease. Thirty-nine of 53 patients with T3 and T4 lesions, who were followed for a minimum of 30 months (30-56 months) are still alive with local control. Details of treatment techniques, dosimetry, results and complications are presented.
Collapse
|